| Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium (NCT02928692) | RenJi Hospital | 2016-11-01 |
| Randomized AmnioFix Study During Radical Prostatectomy (NCT02645591) | M.D. Anderson Cancer Center | 2016-11-01 |
| CTC Immune Checkpoint (NCT02456571) | Duke University | 2016-11-01 |
| Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer (NCT03889119) | Hoag Memorial Hospital Presbyterian | 2016-10-21 |
| Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor Malignancies (NCT02913131) | Rahul Aggarwal | 2016-10-20 |
| Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy (NCT02903368) | Dana-Farber Cancer Institute | 2016-10-19 |
| Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer (NCT02770391) | Case Comprehensive Cancer Center | 2016-10-17 |
| HDR Focal: Feasibility Study (NCT02918253) | University Health Network, Toronto | 2016-10-14 |
| Glycosylation of Exosomes in Prostate and Urothelial Carcinoma (NCT04960956) | Indiana University | 2016-10-13 |
| MRI With C13 Pilot Study Prostate Cancer (NCT02450201) | University of California, San Francisco | 2016-10-12 |
| Hypofractionated Radiotherapy for Prostate Cancer (NCT03851926) | Consorci Sanitari de Terrassa | 2016-10-05 |
| SPCG17: Prostate Cancer Active Surveillance Trigger Trial (NCT02914873) | Uppsala University | 2016-10-03 |
| 5 Fractions of Pelvic SABR With Intra Prostatic SABR (NCT02911636) | Andrew Loblaw | 2016-10-01 |
| RADTOX: Measuring Radiation Toxicity Using Circulating DNA (NCT02941029) | University of Florida | 2016-10-01 |
| Charité HT-Prostate (NCT04159051) | Charite University, Berlin, Germany | 2016-10-01 |
| Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE) (NCT02704832) | Institut Bergonié | 2016-09-30 |
| Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients (NCT02919111) | University of California, San Francisco | 2016-09-23 |
| Pivotal Study of MRI-guided Transurethral Ultrasound Ablation in Patients With Localized Prostate Cancer (NCT02766543) | Profound Medical Inc. | 2016-09-21 |
| Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041 (NCT02826382) | Five Eleven Pharma, Inc. | 2016-09-20 |
| PACCT: Partnering Around Cancer Clinical Trials (NCT02906241) | Susan Eggly | 2016-09-20 |
| Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence (NCT02918357) | University of California, San Francisco | 2016-09-15 |
| Living With Prostate Cancer (LPC) (NCT03177759) | Vancouver Prostate Centre | 2016-09-09 |
| PET-CT/MRI in the Radiotherapy for Prostate Cancer (NCT02816840) | Xuzhou Medical University | 2016-09-01 |
| Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer (NCT02911922) | Weill Medical College of Cornell University | 2016-09-01 |
| Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201 (NCT02887976) | GU Research Network, LLC | 2016-09-01 |
| The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancer (NCT02840552) | Sir Mortimer B. Davis - Jewish General Hospital | 2016-09-01 |
| Safety and Efficacy of Firmagon® (Degarelix) for Injection (NCT02886598) | Ferring Pharmaceuticals | 2016-09-01 |
| Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial) (NCT02543255) | University Health Network, Toronto | 2016-09-01 |
| Reducing Sedentary Behaviour With Technology (NCT02911649) | University Health Network, Toronto | 2016-09-01 |
| Improving Evidence-Based Care for Cancer Patients (NCT03207594) | Medical University of South Carolina | 2016-09-01 |
| Preference-based Comparative Study on Definitive Radiotherapy of Prostate Cancer With Protons (NCT02766686) | Technische Universität Dresden | 2016-09-01 |
| Assessment of Bone Loss in Men Receiving Treatment for Prostate Cancer (NCT02785627) | Prof Janet Brown | 2016-09-01 |
| Prostatic Artery Embolization Before Radical Prostatectomy in Prostate Cancer: A Proof-of-concept Study (NCT02917161) | Dominik Abt | 2016-09-01 |
| A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057 (NCT02916537) | Cancer Targeted Technology | 2016-09-01 |
| Utility of Dynamic Variables Measured by Calibrated Pulse Contour Analysis of Oesophageal Doppler Monitor for Predicting Fluid Responsiveness During Robot-Assisted Laparoscopic Prostatectomy (NCT02886546) | Hallym University Kangnam Sacred Heart Hospital | 2016-09-01 |
| A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancer (NCT02747342) | Atridia Pty Ltd. | 2016-09-01 |
| Evaluation of Late Toxicity Following Intensity-Modulated Radiotherapy and Two Image-Guided Strategies With Corresponding Treatment Margins. (NCT03254420) | Institut du Cancer de Montpellier - Val d'Aurelle | 2016-08-30 |
| Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination Thru Engagement in Mindfulness Education (NCT02871752) | Northwestern University | 2016-08-10 |
| Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castration-Resistant Prostate Cancer (NCT02856100) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-08-03 |
| ADT Exercise Trial and Economic Analysis (NCT02834416) | University Health Network, Toronto | 2016-08-01 |
| A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer (NCT04147806) | Albert Einstein College of Medicine | 2016-08-01 |
| Study of Carbon Dioxide Exchange Patterns During Robotic Prostatectomies (NCT02114164) | OhioHealth | 2016-08-01 |
| 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases (NCT02721433) | Ottawa Hospital Research Institute | 2016-08-01 |
| Outcomes From a RCT Comparing Preventive Versus Delayed Ligation of DVC During Robot-assisted Radical Prostatectomy (NCT03351088) | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 2016-08-01 |
| Improving Bio-availability of the Expensive Oral Oncolytic Drug Abiraterone by Food Intake (NCT02883166) | Radboud University Medical Center | 2016-08-01 |
| Hypofractionation Proton Beam Therapy With Concurrent Treatment of Prostate and Pelvic Nodes for Prostate Cancer (NCT02874014) | Mayo Clinic | 2016-07-25 |
| Improving Health Literacy in African-American Prostate Cancer Patients (NCT03322891) | Emory University | 2016-07-21 |
| Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning (NCT02681614) | Case Comprehensive Cancer Center | 2016-07-21 |
| CHAMP: A Randomized Controlled Trial of High-intensity Aerobic and Resistance Exercise for Metastatic Prostate Cancer (NCT02613273) | University of California, San Francisco | 2016-07-18 |
| Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes (NCT02917798) | Memorial Sloan Kettering Cancer Center | 2016-07-12 |
| A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer (NCT02844699) | Panacela Labs LLC | 2016-07-01 |
| Quell Opioid Reduction and Pain Relief in Patients With Cancer (NCT02809846) | Scripps Translational Science Institute | 2016-07-01 |
| Improved Prostate Cancer Diagnosis - Combination of Rapid Prebiopsy Magnetic Resonance Imaging and Biomarkers (NCT02844829) | Turku University Hospital | 2016-07-01 |
| Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer (NCT02833883) | Memorial Sloan Kettering Cancer Center | 2016-07-01 |
| Integration of Cancer Health Activities Into African American Churches (NCT03178383) | University of Maryland, College Park | 2016-07-01 |
| FACBC Prostate Therapy Response (NCT02830880) | Emory University | 2016-07-01 |
| Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate Cancer (NCT02478125) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-07-01 |
| Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy (NCT02252978) | Wake Forest University Health Sciences | 2016-07-01 |
| Ibrutinib as Neoadjuvant Therapy in Localized Prostate Cancer (NCT02643667) | Washington University School of Medicine | 2016-07-01 |
| Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients (NCT02997709) | University of Miami | 2016-06-24 |
| Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer (NCT02339168) | University of California, Davis | 2016-06-22 |
| Optical Tomography in Prostate Cancer (NCT03215992) | Columbia University | 2016-06-13 |
| Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone (NCT02640534) | Swiss Cancer Institute | 2016-06-10 |
| A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance (NCT02799745) | Astellas Pharma Global Development, Inc. | 2016-06-09 |
| Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer (NCT02825875) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-06-08 |
| Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy (NCT02220829) | Sir Mortimer B. Davis - Jewish General Hospital | 2016-06-01 |
| A Study of Definitive Therapy to Treat Prostate Cancer (NCT02716974) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-06-01 |
| Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer (NCT02796898) | Tyme, Inc | 2016-06-01 |
| MRI Versus PSA in Prostate Cancer Screening (NCT02799303) | Sunnybrook Health Sciences Centre | 2016-06-01 |
| Focal ExAblate MR-Guided Focused Ultrasound Treatment for Management of Organ-Confined Intermediate Risk Prostate Cancer (NCT02968784) | InSightec | 2016-06-01 |
| IG-VMAT for Localized Prostate Cancer (NCT02934685) | Beijing Hospital | 2016-06-01 |
| Deformable Registration of Multi-parametric MRI to Intra-operative Transrectal Ultrasound for Prostate Brachytherapy (NCT02790216) | Sheba Medical Center | 2016-06-01 |
| Retrograde Perfusion Sphinterometry and Autologous Sling to Improve Urinary Continence in Robotic Radical Prostatectomy (NCT03050996) | Istituto Auxologico Italiano | 2016-06-01 |
| 18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment (NCT02680041) | Blue Earth Diagnostics | 2016-06-01 |
| Serial mpMRI (Multi Parametric Magnetic Resonance Imaging) Scanning in Prostate Cancer After Androgen Deprivation Therapy and RadioTherapy (NCT02721784) | University College, London | 2016-06-01 |
| A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer (NCT02608359) | Johnson & Johnson Private Limited | 2016-05-31 |
| PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer (NCT02735252) | University of California, San Francisco | 2016-05-25 |
| MRI Guided SBRT for Localized Prostate Cancer (NCT03778112) | Rush University Medical Center | 2016-05-23 |
| Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study) (NCT03703778) | Chinese University of Hong Kong | 2016-05-22 |
| Miami Membrane for Potency (MMEP) Trial (NCT02710422) | University of Miami | 2016-05-17 |
| AASUR in High Risk Prostate Cancer (NCT02772588) | Memorial Sloan Kettering Cancer Center | 2016-05-12 |
| Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer (NCT02769962) | National Cancer Institute (NCI) | 2016-05-09 |
| Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer (NCT02452008) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-05-03 |
| Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES) (NCT02768363) | Candel Therapeutics, Inc. | 2016-05-01 |
| Evaluation of PSA Blood Levels Prior to and After Digital Rectal Examination (NCT02747563) | Kaplan Medical Center | 2016-05-01 |
| 18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients. (NCT02969564) | Valentina Garibotto | 2016-05-01 |
| ClariCore™ Biopsy System in Patients Undergoing Radical Retropubic Prostatectomy (NCT02773940) | Precision Biopsy, Inc. | 2016-05-01 |
| A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer (NCT02726009) | Ferring Pharmaceuticals | 2016-05-01 |
| Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer (NCT02692105) | British Columbia Cancer Agency | 2016-05-01 |
| Postoperative Patient Comfort and Quality of Micturition in Suprapubic Tube vs. Transurethral Catheterization After RARP (NCT02812173) | St. Antonius Hospital Gronau | 2016-05-01 |
| Phase II Laser Focal Therapy of Prostate Cancer (NCT02243033) | HALO Diagnostics | 2016-05-01 |
| Correlation Between SUV on 68Ga-HBED-CC-PSMA and Gleason Score in Prostate Cancer (NCT02796807) | Sir Mortimer B. Davis - Jewish General Hospital | 2016-05-01 |
| The BARCODE 1 Pilot Study (NCT03158922) | Institute of Cancer Research, United Kingdom | 2016-04-29 |
| Stereotactic Body Radiation for Prostate Oligometastases (NCT02680587) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-04-28 |
| French Validation of the Memorial Anxiety Scale for Patients With Prostate Cancer. (NCT03331068) | Institut Paoli-Calmettes | 2016-04-26 |
| A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease (NCT02663908) | Ferring Pharmaceuticals | 2016-04-19 |
| Validation Study on the Impact of Decipher® Testing - VANDAAM Study (NCT02723734) | H. Lee Moffitt Cancer Center and Research Institute | 2016-04-13 |
| Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone Metastases (NCT02582749) | Ajjai Alva, MD | 2016-04-01 |
| STHLM3-MR: Comparing Standard With Targeted Prostate Biopsies (NCT02788825) | Karolinska Institutet | 2016-04-01 |
| Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer" (NCT03209492) | Takeda | 2016-04-01 |